Search Results - "Gallego, R. Álvarez"

P-182 Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer by Gallego, R. Álvarez, Cid, R. Pazo, López de San Vicente, B., Macarulla, T., Martinez de Castro, E., Goldaraz, F. Garicano, Granja, M., Ghanem, I., Martinez-Galán, J., Fernández, P. Ribera, Beveridge, R. Díaz, Valadés, J. Martín, Ángeles, C., Cubillo, A.

Get full text

P-118 Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study by Santos Vivas, C., Salva, F., Fernández-Rodríguez, C., Alonso Orduña, V., Losa, F., Paez, D., Vidal, J., Salud, A., Ribera Fernández, P., Safont Aguilera, M., Tarazona, N., Hernández-Yagüe, X., Layos Romero, L., Garcia-Carbonero, R., Rivera, F., Álvarez Gallego, R., Bellosillo, B., Montagut, C.

Get full text

Therapeutic management of epithelial ovarian cancer during pregnancy by Minig, L., Otaño, L., Diaz-Padilla, I., Alvarez Gallego, R., Patrono, M. G., Valero de Bernabé, J.

“…Epithelial ovarian cancer (EOC) during pregnancy is a rare condition. The diagnosis and treatment strategies are therefore not well defined. The evidence is…”
Get full text

722TiP CLAUDIO-01: A multicentric phase I/II trial to evaluate the safety and efficacy of SOT102 as monotherapy and in combination with standard of care (SoC) in patients with gastric, gastroesophageal junction(GEJ), and pancreatic adenocarcinoma by Obermannova, R., Hollebecque, A., Macarulla, T., Alvarez Gallego, R., Van Cutsem, E., Conde, R.S., Hanauske, A-R., Boura, V., Tabernero, J.

Get full text

932P Survival in patients with relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) treated with pembrolizumab or cetuximab-based therapy: A real-worlddata study with the TriNetX platform by Ugidos De La Varga, L., Ruiz del Arbol, N., Hernández-Ibarburu, G., Delia, E., Peinado, P., Torres Velasco, M., Alvarez Gallego, R., Munoz Sanchez-Miguel, C.G., Garcia Morillo, M., Toledano, C., Cubillo, A.

Get full text

1749P COVID-19 impact and predictive factors for mortality in cancer patients by Sanz Garcia, E., Peinado, P., Moreno, I., Dorta, M., Alvarez, B., Alvarez Gallego, R., Madurga, R., Rodriguez Pascual, J., Ugidos, L., Muñoz, C., Garcia-Rico, E., Cubillo, A.

Get full text

1760P COVID-19 severe pneumonia in cancer patients: Impact and predictive factors by Peinado, P., Sanz Garcia, E., Moreno, I., Dorta, M., Alvarez, B., Alvarez Gallego, R., Madurga, R., Ugidos, L., Rodriguez Pascual, J., Muñoz, C., Garcia-Rico, E., Cubillo, A.

Get full text

416P Randomized phase II trial of second-line FOLFIRI-panitumumab vs FOLFIRI alone in Ras wild type (wt) metastatic colorectal cancer (mCRC) patients beyond progression to first-line FOLFOX-panitumumab: BEYOND study (GEMCAD 17-01) by Aparicio, J., Manrique, A.C. Virgili, Capdevila, J., Boza, F. Muñoz, Galván, P., Richart, P., Oliveres, H., Paez, D., Hernando, J., Serrano, S. Garcia, Vera, R., Hernandez, X., Gallego, R. Alvarez, Riesco-Martinez, M.C., García de Albeniz, X., Maurel, J.

Get full text

Systemic administration of the hyaluronidase-expressing oncolytic adenovirus VCN-01 in patients with advanced or metastatic pancreatic cancer: First-in-human clinical trial by Garcia-Carbonero, R., Gil Martín, M., Alvarez Gallego, R., Macarulla Mercade, T., Riesco Martinez, M.C., Guillen-Ponce, C., Vidal, N., Real, F.X., Moreno, R., Maliandi, V., Mato-Berciano, A., Bazan-Peregrino, M., Capella, G., Alemany, R., Blasi, E., Blasco, C., Cascallo, M., Salazar, R.

Get full text

459PProof of concept clinical study by US-guided intratumor injection of VCN-01, an oncolytic adenovirus expressing hyaluronidase in patients with pancreatic cancer by Hidalgo, M, Bazan-Peregrino, M, Laquente, B, Gallego, R Alvarez, Mato-Berciano, A, Giménez-Alejandre, M, Maliandi, V, Martinez, M C Riesco, Moreno, R, Morell, M, Perez-Carreras, M, Gornals, J, Prados, S, Capella, G, Alemany, R, Salazar, R, Blasi, E, Blasco, C, Cascallo, M, Garcia-Carbonero, R

“…Abstract Background Dense stroma is a hallmark of hard-to-treat cancers such as pancreatic adenocarcinoma. VCN-01 oncolytic adenovirus is designed to replicate…”
Get full text

710PSystemic administration of the hyaluronidase-expressing oncolytic adenovirus VCN-01 in patients with advanced or metastatic pancreatic cancer: First-in-human clinical trial by Garcia-Carbonero, R, Gil Martín, M, Alvarez Gallego, R, Macarulla Mercade, T, Riesco Martinez, M C, Guillen-Ponce, C, Vidal, N, Real, F X, Moreno, R, Maliandi, V, Mato-Berciano, A, Bazan-Peregrino, M, Capella, G, Alemany, R, Blasi, E, Blasco, C, Cascallo, M, Salazar, R

“…Abstract Background Expression of hyaluronidase from the selective oncolytic adenovirus VCN-01 modifies tumor matrix in pancreatic tumours. Such effect…”
Get full text

459P - Proof of concept clinical study by US-guided intratumor injection of VCN-01, an oncolytic adenovirus expressing hyaluronidase in patients with pancreatic cancer by Hidalgo, M., Bazan-Peregrino, M., Laquente, B., Gallego, R Alvarez, Mato-Berciano, A., Giménez-Alejandre, M., Maliandi, V., Martinez, M C Riesco, Moreno, R., Morell, M., Perez-Carreras, M., Gornals, J., Prados, S., Capella, G., Alemany, R., Salazar, R., Blasi, E., Blasco, C., Cascallo, M., Garcia-Carbonero, R.

“…Dense stroma is a hallmark of hard-to-treat cancers such as pancreatic adenocarcinoma. VCN-01 oncolytic adenovirus is designed to replicate in cancer cells…”
Get full text

Proof of concept clinical study by US-guided intratumor injection of VCN-01, an oncolytic adenovirus expressing hyaluronidase in patients with pancreatic cancer by Hidalgo, M., Bazan-Peregrino, M., Laquente, B., Gallego, R Alvarez, Mato-Berciano, A., Giménez-Alejandre, M., Maliandi, V., Martinez, M C Riesco, Moreno, R., Morell, M., Perez-Carreras, M., Gornals, J., Prados, S., Capella, G., Alemany, R., Salazar, R., Blasi, E., Blasco, C., Cascallo, M., Garcia-Carbonero, R.

Get full text

710P - Systemic administration of the hyaluronidase-expressing oncolytic adenovirus VCN-01 in patients with advanced or metastatic pancreatic cancer: First-in-human clinical trial by Garcia-Carbonero, R., Gil Martín, M., Alvarez Gallego, R., Macarulla Mercade, T., Riesco Martinez, M.C., Guillen-Ponce, C., Vidal, N., Real, F.X., Moreno, R., Maliandi, V., Mato-Berciano, A., Bazan-Peregrino, M., Capella, G., Alemany, R., Blasi, E., Blasco, C., Cascallo, M., Salazar, R.

“…Expression of hyaluronidase from the selective oncolytic adenovirus VCN-01 modifies tumor matrix in pancreatic tumours. Such effect enhances gemcitabine uptake…”
Get full text

A Prospective Observational Study of the Impact of Stereotactic Body Radiotherapy (SBRT) As a Neoadjuvant Strategy of Chemoradiation in Pancreatic Cancer by Rubio, C., Chen, X., Lopez, M., Hernando, O., Sanchez, E., Montero, A., Aranda, M. Garcia, Ciervide, R., Valero, J.J., Alonso, R., Vicente, E., Quijano, Y., Cubillo, A., Gallego, R. Alvarez, Prados, S., Plaza, C., Pérez, J.M., Garcia, J., Zucca, D., Leton, P. Fernandez

Get full text